Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
A beginner-friendly intro to world stock dividend ETFs, covering basics like yields, diversification, and how to pick your first fund.
23,029 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
In June, affordable stock ideas can offer surprising upside for patient investors. This article breaks down three und...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
Big-name bets via 13F filings often reveal more about risk management than marketing hype. This quarter, billionaire ...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
Progressive Insurance fell today as markets weighed mixed quarterly results. This article breaks down the numbers, ex...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
POET Technologies posted a quarterly miss as a Lumilens deal slows and litigation casts a shadow over growth prospect...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
Cisco stock is at a pivotal crossroads as AI infrastructure demand accelerates. This article weighs targets, catalyst...